Related Experiment Video

Updated: Dec 5, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.3K

CAMK2N1 suppresses hepatoma growth through inhibiting E2F1-mediated cell-cycle signaling

Jei-Ming Peng1, Ruo-Han Tseng2, Tsung-Chieh Shih2

  • 1Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Taoyuan, 333, Taiwan; Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Cancer Letters
|October 17, 2020
PubMed

Insights

Calcium/calmodulin-dependent protein kinase II gamma (CAMK2N1) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Its downregulation promotes HCC development by deregulating cell cycle genes, offering potential therapeutic targets.

Area of Science:

  • Molecular oncology
  • Cancer genetics
  • Cell cycle regulation

Background:

  • Human kinome/phosphatome screening identified CAMK2N1 as a suppressor of hepatocellular carcinoma (HCC).
  • CAMK2N1 is downregulated in 47% of HCC cases, correlating with poor prognosis.
  • Mechanisms for CAMK2N1 downregulation include genomic deletion and promoter hypermethylation.

Purpose of the Study:

  • To investigate the role of CAMK2N1 as a tumor suppressor in HCC.
  • To elucidate the molecular mechanisms by which CAMK2N1 regulates cell proliferation and the cell cycle.
  • To explore the therapeutic potential of targeting CAMK2N1 in HCC.

Main Methods:

  • Gene expression analysis and functional assays (silencing/ectopic expression) in HCC cells.
  • In vivo xenograft tumor growth studies in nude mice.
  • Comparative proteomics and promoter assays to identify downstream targets and regulatory pathways.

Main Results:

  • CAMK2N1 silencing enhanced HCC cell proliferation, colony formation, and tumor growth, while ectopic expression suppressed these.
  • CAMK2N1 silencing transcriptionally deregulated E2F1-target genes, impacting cell cycle progression.
  • CAMK2N1 suppressed E2F1 activity, induced P27/KIP1 expression, and inhibited cell cycle progression.

Conclusions:

  • CAMK2N1 is a novel tumor suppressor gene located at 1p36 that inhibits E2F1 transcriptional activity.
  • CAMK2N1 regulates cell cycle progression via P27/KIP1 induction and its interaction with CAMK2.
  • CAMK2N1 deregulation contributes to tumorigenesis and represents a potential therapeutic target for HCC.
Keywords:
Ca(2+)/calmodulin (CaM)-dependent kinasesCalcium/calmodulin-dependent protein kinase II inhibitor AlphaCell cycle checkpointsHCCHepatocellular carcinoma

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.1K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.3K